{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:12:13Z","timestamp":1778667133752,"version":"3.51.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"DOI":"10.1007\/s11897-026-00763-y","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:24:13Z","timestamp":1778664253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Continuous-Flow: The Next Wave of Fully Implantable LVADs and Total Artificial Hearts"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-2733","authenticated-orcid":false,"given":"Tasuku","family":"Hada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Baranowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel T.","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"7","key":"763_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamacardio.2018.0522","volume":"3","author":"LW Miller","year":"2018","unstructured":"Miller LW, Rogers JG. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review. JAMA Cardiol. 2018;3(7):650\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2018.0522.","journal-title":"JAMA Cardiol"},{"issue":"14","key":"763_CR2","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jacc.2023.07.019","volume":"82","author":"RJ Tedford","year":"2023","unstructured":"Tedford RJ, Leacche M, Lorts A, Drakos SG, Pagani FD, Cowger J. Durable Mechanical Circulatory Support: JACC Scientific Statement. J Am Coll Cardiol. 2023;82(14):1464\u201381. https:\/\/doi.org\/10.1016\/j.jacc.2023.07.019.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"763_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11886-018-1037-0","volume":"20","author":"PH Zhang","year":"2018","unstructured":"Zhang PH, Kresh JY. Circulatory Mechanotherapeutics: Moving with the Force. Curr Cardiol Rep. 2018;20(10):94. https:\/\/doi.org\/10.1007\/s11886-018-1037-0.","journal-title":"Curr Cardiol Rep"},{"issue":"23","key":"763_CR4","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","volume":"361","author":"MS Slaughter","year":"2009","unstructured":"Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241\u201351. https:\/\/doi.org\/10.1056\/NEJMoa0909938.","journal-title":"N Engl J Med"},{"issue":"12","key":"763_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","volume":"328","author":"MR Mehra","year":"2022","unstructured":"Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022;328(12):1233\u201342. https:\/\/doi.org\/10.1001\/jama.2022.16197.","journal-title":"JAMA"},{"key":"763_CR6","doi-asserted-by":"publisher","first-page":"1645705","DOI":"10.3389\/fcvm.2025.1645705","volume":"12","author":"J Mao","year":"2025","unstructured":"Mao J, Gao Z, Yu W, Yu Y. Physiologic effects of different hemodynamic patterns of LVAD. Front Cardiovasc Med. 2025;12:1645705. https:\/\/doi.org\/10.3389\/fcvm.2025.1645705.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"763_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1525-1594.2010.00996.x","volume":"34","author":"Y Guan","year":"2010","unstructured":"Guan Y, Karkhanis T, Wang S, Rider A, Koenig SC, Slaughter MS, et al. Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults. Artif Organs. 2010;34(7):529\u201336. https:\/\/doi.org\/10.1111\/j.1525-1594.2010.00996.x.","journal-title":"Artif Organs"},{"issue":"12","key":"763_CR8","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/MAT.0000000000001690","volume":"68","author":"HS Lumish","year":"2022","unstructured":"Lumish HS, Cagliostro B, Braghieri L, Bohn B, Mondellini GM, Antler K, et al. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy. ASAIO J. 2022;68(12):1450\u20138. https:\/\/doi.org\/10.1097\/MAT.0000000000001690.","journal-title":"ASAIO J"},{"issue":"4","key":"763_CR9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.athoracsur.2010.04.093","volume":"90","author":"VK Topkara","year":"2010","unstructured":"Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90(4):1270\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.04.093.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"763_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.healun.2015.03.011","volume":"34","author":"K Takeda","year":"2015","unstructured":"Takeda K, Takayama H, Colombo PC, Yuzefpolskaya M, Fukuhara S, Han J, et al. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transpl. 2015;34(8):1024\u201332. https:\/\/doi.org\/10.1016\/j.healun.2015.03.011.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"763_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/ncpcardio1397","volume":"6","author":"PF Davies","year":"2009","unstructured":"Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6(1):16\u201326. https:\/\/doi.org\/10.1038\/ncpcardio1397.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"763_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Y Alexander","year":"2021","unstructured":"Alexander Y, Osto E, Schmidt-Trucksass A, Shechter M, Trifunovic D, Duncker DJ, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc Res. 2021;117(1):29\u201342. https:\/\/doi.org\/10.1093\/cvr\/cvaa085.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"763_CR13","doi-asserted-by":"publisher","first-page":"e004670","DOI":"10.1161\/circheartfailure.117.004670","volume":"11","author":"SN Purohit","year":"2018","unstructured":"Purohit SN, Cornwell WK 3rd, Pal JD, Lindenfeld J, Ambardekar AV. Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices. Circ Heart Fail. 2018;11(6):e004670. https:\/\/doi.org\/10.1161\/circheartfailure.117.004670.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"763_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11886-021-01534-y","volume":"23","author":"S Sathianathan","year":"2021","unstructured":"Sathianathan S, Bhat G, Dowling R. Vasoplegia from Continuous Flow Left Ventricular Assist Devices. Curr Cardiol Rep. 2021;23(8):101. https:\/\/doi.org\/10.1007\/s11886-021-01534-y.","journal-title":"Curr Cardiol Rep"},{"issue":"15","key":"763_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","volume":"56","author":"N Uriel","year":"2010","unstructured":"Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56(15):1207\u201313. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.016.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"763_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.healun.2015.12.024","volume":"35","author":"K Muthiah","year":"2016","unstructured":"Muthiah K, Connor D, Ly K, Gardiner EE, Andrews RK, Qiao J, et al. Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices. J Heart Lung Transpl. 2016;35(6):743\u201351. https:\/\/doi.org\/10.1016\/j.healun.2015.12.024.","journal-title":"J Heart Lung Transpl"},{"issue":"12","key":"763_CR17","doi-asserted-by":"publisher","first-page":"e6341","DOI":"10.7759\/cureus.6341","volume":"11","author":"I Ahsan","year":"2019","unstructured":"Ahsan I, Faraz A, Mehmood A, Ullah W, Ghani AR. Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD). Cureus. 2019;11(12):e6341. https:\/\/doi.org\/10.7759\/cureus.6341.","journal-title":"Cureus"},{"issue":"2","key":"763_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","volume":"134","author":"CE Tabit","year":"2016","unstructured":"Tabit CE, Chen P, Kim GH, Fedson SE, Sayer G, Coplan MJ, et al. Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016;134(2):141\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019692.","journal-title":"Circulation"},{"issue":"1","key":"763_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.healun.2017.06.001","volume":"37","author":"CE Tabit","year":"2018","unstructured":"Tabit CE, Coplan MJ, Chen P, Jeevanandam V, Uriel N, Liao JK. Tumor necrosis factor-alpha levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transpl. 2018;37(1):107\u201315. https:\/\/doi.org\/10.1016\/j.healun.2017.06.001.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"763_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/0391398820951811","volume":"44","author":"V Kittipibul","year":"2021","unstructured":"Kittipibul V, Vutthikraivit W, Kewcharoen J, Rattanawong P, Tantrachoti P, Putthapiban P, et al. Angiotensin II antagonists and gastrointestinal bleeding in left ventricular assist devices: A systematic review and meta-analysis. Int J Artif Organs. 2021;44(3):215\u201320. https:\/\/doi.org\/10.1177\/0391398820951811.","journal-title":"Int J Artif Organs"},{"issue":"2","key":"763_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ejhf.2746","volume":"25","author":"N Uriel","year":"2023","unstructured":"Uriel N, Milano C, Agarwal R, Lee S, Cleveland J, Goldstein D, et al. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis. Eur J Heart Fail. 2023;25(2):286\u201394. https:\/\/doi.org\/10.1002\/ejhf.2746.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"763_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCHEARTFAILURE.113.000878","volume":"7","author":"UP Jorde","year":"2014","unstructured":"Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Costello J, Thomas SS, et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circulation: Heart Fail. 2014;7(2):310\u20139. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000878.","journal-title":"Circulation: Heart Fail"},{"issue":"1","key":"763_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11897-013-0172-6","volume":"11","author":"J Holtz","year":"2014","unstructured":"Holtz J, Teuteberg J. Management of aortic insufficiency in the continuous flow left ventricular assist device population. Curr Heart Fail Rep. 2014;11(1):103\u201310. https:\/\/doi.org\/10.1007\/s11897-013-0172-6.","journal-title":"Curr Heart Fail Rep"},{"issue":"10","key":"763_CR24","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.healun.2010.05.018","volume":"29","author":"SW Pak","year":"2010","unstructured":"Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transpl. 2010;29(10):1172\u20136. https:\/\/doi.org\/10.1016\/j.healun.2010.05.018.","journal-title":"J Heart Lung Transpl"},{"issue":"11","key":"763_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jchf.2018.07.012","volume":"6","author":"LK Truby","year":"2018","unstructured":"Truby LK, Garan AR, Givens RC, Wayda B, Takeda K, Yuzefpolskaya M, et al. Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry. JACC Heart Fail. 2018;6(11):951\u201360. https:\/\/doi.org\/10.1016\/j.jchf.2018.07.012.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"763_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacc.2003.09.052","volume":"43","author":"M Vatta","year":"2004","unstructured":"Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, et al. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004;43(5):811\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.052.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"763_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MAT.0000000000001875","volume":"69","author":"M Yuzefpolskaya","year":"2023","unstructured":"Yuzefpolskaya M, Ladanyi A, Bokhari S, Jorde UP, Colombo PC. Effect of Left Ventricular Unloading by Pump Speed Adjustment on Myocardial Flow in Continuous-flow Left Ventricular Assist Device Patients. ASAIO J. 2023;69(5):460\u20136. https:\/\/doi.org\/10.1097\/MAT.0000000000001875.","journal-title":"ASAIO J"},{"issue":"5","key":"763_CR28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.athoracsur.2011.01.027","volume":"91","author":"T Krabatsch","year":"2011","unstructured":"Krabatsch T, Schweiger M, Dandel M, Stepanenko A, Drews T, Potapov E, et al. Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg. 2011;91(5):1335\u201340. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.01.027.","journal-title":"Ann Thorac Surg"},{"key":"763_CR29","unstructured":"CorWave. https:\/\/www.corwave.com\/ (2025). Accessed DEC 10 2025."},{"issue":"11","key":"763_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/aor.70036","volume":"49","author":"J D\u2019Andria Ursoleo","year":"2025","unstructured":"D\u2019Andria Ursoleo J. First-In-Human Implantation of CorWave\u2019s Next-Gen Left Ventricular Assist Device\u2014Has a New Era in Long-Term Mechanical Circulatory Support Just Begun? Artif Organs. 2025;49(11):1609\u201310. https:\/\/doi.org\/10.1111\/aor.70036.","journal-title":"Artif Organs"},{"issue":"8","key":"763_CR31","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.healun.2025.03.001","volume":"44","author":"FD Pagani","year":"2025","unstructured":"Pagani FD, Cowger JA, Jorde UP, Salerno C, Naka Y, Bhat G, et al. Design and rationale for the clinical investigation of a novel, magnetically levitated left ventricular assist device for the treatment of refractory heart failure. J Heart Lung Transpl. 2025;44(8):1290\u20139. https:\/\/doi.org\/10.1016\/j.healun.2025.03.001.","journal-title":"J Heart Lung Transpl"},{"issue":"Supplement 2","key":"763_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/01.mat.0000944248.28835.5e","volume":"69","author":"P Coghill","year":"2023","unstructured":"Coghill P, Long JW, Dasse K, Lin F, Chen C. P107: In Vitro, Benchtop Testing Indicates Improved Hemocompatibility with a New Magnetically Levitated VAD. ASAIO J. 2023;69(Supplement 2):171. https:\/\/doi.org\/10.1097\/01.mat.0000944248.28835.5e.","journal-title":"ASAIO J"},{"issue":"2","key":"763_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.21037\/acs-2020-cfmcs-19","volume":"10","author":"CR Bartoli","year":"2021","unstructured":"Bartoli CR, Gohean JR, Smalling RW. Reinventing the displacement left ventricular assist device in the continuous-flow era: TORVAD, the first toroidal-flow left ventricular assist device. Ann Cardiothorac Surg. 2021;10(2):274\u20137. https:\/\/doi.org\/10.21037\/acs-2020-cfmcs-19.","journal-title":"Ann Cardiothorac Surg"},{"issue":"3","key":"763_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13239-019-00419-0","volume":"10","author":"JR Gohean","year":"2019","unstructured":"Gohean JR, Larson ER, Longoria RG, Kurusz M, Smalling RW. Preload Sensitivity with TORVAD Counterpulse Support Prevents Suction and Overpumping. Cardiovasc Eng Technol. 2019;10(3):520\u201330. https:\/\/doi.org\/10.1007\/s13239-019-00419-0.","journal-title":"Cardiovasc Eng Technol"},{"issue":"3","key":"763_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MAT.0000000000000190","volume":"61","author":"JR Gohean","year":"2015","unstructured":"Gohean JR, George MJ, Chang KW, Larson ER, Pate TD, Kurusz M, et al. Preservation of native aortic valve flow and full hemodynamic support with the TORVAD using a computational model of the cardiovascular system. ASAIO J. 2015;61(3):259\u201365. https:\/\/doi.org\/10.1097\/MAT.0000000000000190.","journal-title":"ASAIO J"},{"issue":"1","key":"763_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.healun.2022.10.011","volume":"42","author":"SR Allen","year":"2023","unstructured":"Allen SR, Slaughter MS, Ahmed MM, Bartoli CR, Dhingra R, Egnaczyk GF, et al. COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transpl. 2023;42(1):33\u20139. https:\/\/doi.org\/10.1016\/j.healun.2022.10.011.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"763_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.athoracsur.2013.10.107","volume":"97","author":"JX Wang","year":"2014","unstructured":"Wang JX, Smith JR, Bonde P. Energy transmission and power sources for mechanical circulatory support devices to achieve total implantability. Ann Thorac Surg. 2014;97(4):1467\u201374. https:\/\/doi.org\/10.1016\/j.athoracsur.2013.10.107.","journal-title":"Ann Thorac Surg"},{"key":"763_CR38","doi-asserted-by":"publisher","unstructured":"Mehta SM, Pae WE Jr., Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP et al. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001;71(3 Suppl):S156-61; discussion S83-4. https:\/\/doi.org\/10.1016\/s0003-4975(00)02641-2","DOI":"10.1016\/s0003-4975(00)02641-2"},{"issue":"6 Suppl","key":"763_CR39","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/s0003-4975(03)00484-3","volume":"75","author":"RD Dowling","year":"2003","unstructured":"Dowling RD, Gray LA Jr., Etoch SW, Laks H, Marelli D, Samuels L, et al. The AbioCor implantable replacement heart. Ann Thorac Surg. 2003;75(6 Suppl):S93\u20139. https:\/\/doi.org\/10.1016\/s0003-4975(03)00484-3.","journal-title":"Ann Thorac Surg"},{"issue":"1\u20133","key":"763_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000075992","volume":"101","author":"OH Frazier","year":"2004","unstructured":"Frazier OH, Dowling RD, Gray LA Jr., Shah NA, Pool T, Gregoric I. The total artificial heart: where we stand. Cardiology. 2004;101(1\u20133):117\u201321. https:\/\/doi.org\/10.1159\/000075992.","journal-title":"Cardiology"},{"issue":"5","key":"763_CR41","doi-asserted-by":"publisher","first-page":"E160","DOI":"10.1111\/j.1525-1594.2009.00992.x","volume":"34","author":"TD Dissanayake","year":"2010","unstructured":"Dissanayake TD, Budgett DM, Hu P, Bennet L, Pyner S, Booth L, et al. A novel low temperature transcutaneous energy transfer system suitable for high power implantable medical devices: performance and validation in sheep. Artif Organs. 2010;34(5):E160\u20137. https:\/\/doi.org\/10.1111\/j.1525-1594.2009.00992.x.","journal-title":"Artif Organs"},{"issue":"4","key":"763_CR42","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/j.healun.2013.01.316","volume":"32","author":"Y Kassif","year":"2013","unstructured":"Kassif Y, Zilbershlag M, Levi M, Plotkin A, Schueler S. A New Universal Wireless Transcutaneous Energy Transfer (TET) System for Implantable LVADs \u2013 Preliminary In Vitro and In Vivo Results. J Heart Lung Transplantation. 2013;32(4):S140\u20131. https:\/\/doi.org\/10.1016\/j.healun.2013.01.316.","journal-title":"J Heart Lung Transplantation"},{"issue":"4","key":"763_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.healun.2019.01.1316","volume":"38","author":"Y Pya","year":"2019","unstructured":"Pya Y, Maly J, Bekbossynova M, Salov R, Schueler S, Meyns B, et al. First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device. J Heart Lung Transpl. 2019;38(4):339\u201343. https:\/\/doi.org\/10.1016\/j.healun.2019.01.1316.","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"763_CR44","doi-asserted-by":"publisher","first-page":"e2020624","DOI":"10.11589\/vad\/e2020624","volume":"6","author":"Y Pya","year":"2020","unstructured":"Pya Y. Transcutaneous Energy Transmission: Can we do it now? VAD J. 2020;6(2):e2020624. https:\/\/doi.org\/10.11589\/vad\/e2020624.","journal-title":"VAD J"},{"issue":"3","key":"763_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21037\/acs-2020-cfmcs-200","volume":"10","author":"Y Pya","year":"2021","unstructured":"Pya Y, Abdiorazova A. Elimination of drive exit line: transcutaneous energy transmission. Ann Cardiothorac Surg. 2021;10(3):393\u20135. https:\/\/doi.org\/10.21037\/acs-2020-cfmcs-200.","journal-title":"Ann Cardiothorac Surg"},{"key":"763_CR46","unstructured":"InvivoPower AB. https:\/\/invivopower.com\/. (2026). Accessed Jan 13 2026."},{"issue":"4","key":"763_CR47","doi-asserted-by":"publisher","first-page":"S457","DOI":"10.1016\/j.healun.2021.01.1270","volume":"40","author":"K Jonsson","year":"2021","unstructured":"Jonsson K, Bern B, Maltese G, Klockar P, Dellgren G. Surgical Development for a Novel Transcutaneous Energy Transfer Method for Long-Term Mechanical Circulatory Support. J Heart Lung Transplantation. 2021;40(4):S457. https:\/\/doi.org\/10.1016\/j.healun.2021.01.1270.","journal-title":"J Heart Lung Transplantation"},{"key":"763_CR48","unstructured":"Corvion. https:\/\/corvion.com\/ (2026). Accessed Jan 13 2026."},{"issue":"5","key":"763_CR49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0002-9149(69)90460-3","volume":"24","author":"DA Cooley","year":"1969","unstructured":"Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24(5):723\u201330. https:\/\/doi.org\/10.1016\/0002-9149(69)90460-3.","journal-title":"Am J Cardiol"},{"issue":"12","key":"763_CR50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41569-022-00723-8","volume":"19","author":"A Vis","year":"2022","unstructured":"Vis A, Arfaee M, Khambati H, Slaughter MS, Gummert JF, Overvelde JTB, et al. The ongoing quest for the first total artificial heart as destination therapy. Nat Rev Cardiol. 2022;19(12):813\u201328. https:\/\/doi.org\/10.1038\/s41569-022-00723-8.","journal-title":"Nat Rev Cardiol"},{"key":"763_CR51","doi-asserted-by":"publisher","unstructured":"Rubin G, Colon MJ, Mahar J, Sunkara A, Yenigalla S, Arabia FA. A device profile of the SynCardia temporary total artificial heart as a bridge-to-transplantation in patients with biventricular failure. Expert Rev Med Devices. 2025;1\u20139. https:\/\/doi.org\/10.1080\/17434440.2025.2606884.","DOI":"10.1080\/17434440.2025.2606884"},{"issue":"3","key":"763_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.healun.2020.11.012","volume":"40","author":"M Carrier","year":"2021","unstructured":"Carrier M, Moriguchi J, Shah KB, Anyanwu AC, Mahr C, Skipper E, et al. Outcomes after heart transplantation and total artificial heart implantation: A multicenter study. J Heart Lung Transpl. 2021;40(3):220\u20138. https:\/\/doi.org\/10.1016\/j.healun.2020.11.012.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"763_CR53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.athoracsur.2022.11.034","volume":"115","author":"J Malas","year":"2023","unstructured":"Malas J, Chen Q, Akhmerov A, Tremblay LP, Egorova N, Krishnan A, et al. Experience With SynCardia Total Artificial Heart as a Bridge to Transplantation in 100 Patients. Ann Thorac Surg. 2023;115(3):725\u201332. https:\/\/doi.org\/10.1016\/j.athoracsur.2022.11.034.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"763_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/aor.14860","volume":"49","author":"A Razumov","year":"2025","unstructured":"Razumov A, Burri M, Zittermann A, Radakovic D, Lauenroth V, Rojas SV, et al. Outcomes after SynCardia(R) temporary total artificial heart implantation: A 20-year single-center experience in 196 patients. Artif Organs. 2025;49(2):266\u201375. https:\/\/doi.org\/10.1111\/aor.14860.","journal-title":"Artif Organs"},{"issue":"2","key":"763_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.36628\/ijhf.2023.0020","volume":"6","author":"MC Tan","year":"2024","unstructured":"Tan MC, Yeo YH, Tham JW, Tan JL, Fong HK, Tan BE, et al. Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE). Int J Heart Fail. 2024;6(2):76\u201381. https:\/\/doi.org\/10.36628\/ijhf.2023.0020.","journal-title":"Int J Heart Fail"},{"issue":"6","key":"763_CR56","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MAT.0000000000000132","volume":"60","author":"G Torregrossa","year":"2014","unstructured":"Torregrossa G, Morshuis M, Varghese R, Hosseinian L, Vida V, Tarzia V, et al. Results with SynCardia total artificial heart beyond 1 year. ASAIO J. 2014;60(6):626\u201334. https:\/\/doi.org\/10.1097\/MAT.0000000000000132.","journal-title":"ASAIO J"},{"key":"763_CR57","doi-asserted-by":"publisher","unstructured":"Itagaki S, Toyoda N, Egorova N, Sun E, Lee T, Boateng P et al. Total artificial heart implantation as a bridge to transplantation in the United States. J Thorac Cardiovasc Surg. 2024;167(1):205\u2009\u2013\u200914 e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.02.058","DOI":"10.1016\/j.jtcvs.2022.02.058"},{"issue":"6","key":"763_CR58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ejcts\/ezu333","volume":"46","author":"P Mohacsi","year":"2014","unstructured":"Mohacsi P, Leprince P. The CARMAT total artificial heart. Eur J Cardiothorac Surg. 2014;46(6):933\u20134. https:\/\/doi.org\/10.1093\/ejcts\/ezu333.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"763_CR59","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1093\/ejcts\/ezs187","volume":"41","author":"P Jansen","year":"2012","unstructured":"Jansen P, van Oeveren W, Capel A, Carpentier A. In vitro haemocompatibility of a novel bioprosthetic total artificial heart. Eur J Cardiothorac Surg. 2012;41(6):e166\u201372. https:\/\/doi.org\/10.1093\/ejcts\/ezs187.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"763_CR60","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/ejcts\/ezv010","volume":"47","author":"C Latremouille","year":"2015","unstructured":"Latremouille C, Duveau D, Cholley B, Zilberstein L, Belbis G, Boughenou MF, et al. Animal studies with the Carmat bioprosthetic total artificial heart. Eur J Cardiothorac Surg. 2015;47(5):e172\u20138. https:\/\/doi.org\/10.1093\/ejcts\/ezv010. discussion e8-9.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"763_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.healun.2017.09.002","volume":"37","author":"C Latr\u00e9mouille","year":"2018","unstructured":"Latr\u00e9mouille C, Carpentier A, Leprince P, Roussel JC, Cholley B, Boissier E, et al. A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study. J Heart Lung Transpl. 2018;37(1):33\u20137. https:\/\/doi.org\/10.1016\/j.healun.2017.09.002.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"763_CR62","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/aor.13959","volume":"45","author":"JJ Han","year":"2021","unstructured":"Han JJ. Aeson-The Carmat total artificial heart is approved for enrollment in the United States. Artif Organs. 2021;45(5):445\u20136. https:\/\/doi.org\/10.1111\/aor.13959.","journal-title":"Artif Organs"},{"key":"763_CR63","unstructured":"CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States. https:\/\/www.carmatsa.com\/en\/press-release\/carmat-receives-fda-conditional-approval-to-initiate-the-second-cohort-of-the-efs-study-in-the-united-states\/ (2025). Accessed Jan 1 2026."},{"issue":"1","key":"763_CR64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ejcts\/ezu321","volume":"47","author":"B Pelletier","year":"2015","unstructured":"Pelletier B, Spiliopoulos S, Finocchiaro T, Graef F, Kuipers K, Laumen M, et al. System overview of the fully implantable destination therapy\u2013ReinHeart-total artificial heart. Eur J Cardiothorac Surg. 2015;47(1):80\u20136. https:\/\/doi.org\/10.1093\/ejcts\/ezu321.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"763_CR65","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/aor.12636","volume":"40","author":"E Cuenca-Navalon","year":"2016","unstructured":"Cuenca-Navalon E, Laumen M, Finocchiaro T, Steinseifer U. Estimation of Filling and Afterload Conditions by Pump Intrinsic Parameters in a Pulsatile Total Artificial Heart. Artif Organs. 2016;40(7):638\u201344. https:\/\/doi.org\/10.1111\/aor.12636.","journal-title":"Artif Organs"},{"issue":"4","key":"763_CR66","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/aor.13830","volume":"45","author":"M Diedrich","year":"2021","unstructured":"Diedrich M, Hildebrand S, Lommel MK, Finocchiaro T, Cuenca E, De Ben H, et al. Experimental investigation of right-left flow balance concepts for a total artificial heart. Artif Organs. 2021;45(4):364\u201372. https:\/\/doi.org\/10.1111\/aor.13830.","journal-title":"Artif Organs"},{"issue":"1","key":"763_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MAT.0000000000001415","volume":"68","author":"MK Brockhaus","year":"2022","unstructured":"Brockhaus MK, Hildebrand S, Diedrich M, Lowes M, De Ben H, Schmitz-Rode T, et al. Downsizing of a Pulsatile Total Artificial Heart-The Effect on Hemolysis. ASAIO J. 2022;68(1):34\u201340. https:\/\/doi.org\/10.1097\/MAT.0000000000001415.","journal-title":"ASAIO J"},{"issue":"10","key":"763_CR68","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/aor.12659","volume":"40","author":"F Graf","year":"2016","unstructured":"Graf F, Rossbroich R, Finocchiaro T, Steinseifer U. Investigation of the Durability of a Diaphragm for a Total Artificial Heart. Artif Organs. 2016;40(10):1016\u201322. https:\/\/doi.org\/10.1111\/aor.12659.","journal-title":"Artif Organs"},{"issue":"5","key":"763_CR69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/aor.14481","volume":"47","author":"B Kirn","year":"2023","unstructured":"Kirn B, Diedrich M, Schmitz-Rode T, Steinseifer U, Jansen SV. Detection of physiological control inputs preload and afterload from intrinsic pump parameters in total artificial heart. Artif Organs. 2023;47(5):817\u201327. https:\/\/doi.org\/10.1111\/aor.14481.","journal-title":"Artif Organs"},{"key":"763_CR70","unstructured":"BiVACOR. https:\/\/bivacor.com\/#home (2025). Accessed DEC 23 2025."},{"issue":"9","key":"763_CR71","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/aor.12827","volume":"40","author":"M Kleinheyer","year":"2016","unstructured":"Kleinheyer M, Timms DL, Tansley GD, Nestler F, Greatrex NA, Frazier OH, et al. Rapid Speed Modulation of a Rotary Total Artificial Heart Impeller. Artif Organs. 2016;40(9):824\u201333. https:\/\/doi.org\/10.1111\/aor.12827.","journal-title":"Artif Organs"},{"key":"763_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/aor.70009","author":"AP McNamee","year":"2025","unstructured":"McNamee AP, Timms D, Nestler F, Bartnikowski N, Smith A, Tansley GD, et al. In Vitro Hemocompatibility of the BiVACOR Total Artificial Heart in Continuous and Pulsatile Flow. Artif Organs. 2025. https:\/\/doi.org\/10.1111\/aor.70009.","journal-title":"Artif Organs"},{"key":"763_CR73","doi-asserted-by":"publisher","unstructured":"Timms DL, Greatrex N, Nestler F, Wu E, Kleinheyer M, Cohn W et al. (127) Preclinical Evaluation of the Bivacor Total Artificial Heart. The Journal of Heart and Lung Transplantation. 2023;42(4, Supplement):S66. https:\/\/doi.org\/10.1016\/j.healun.2023.02.143","DOI":"10.1016\/j.healun.2023.02.143"},{"issue":"10","key":"763_CR74","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/aor.14844","volume":"48","author":"AM Shah","year":"2024","unstructured":"Shah AM. First successful implant of BiVACOR\u2019s Total Artificial Heart. Artif Organs. 2024;48(10):1075\u20136. https:\/\/doi.org\/10.1111\/aor.14844.","journal-title":"Artif Organs"},{"key":"763_CR75","doi-asserted-by":"publisher","unstructured":"Toda K, Loforte A, Tchantchaleishvili V. Report on the 30th Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS). Artif Organs. 2025. https:\/\/doi.org\/10.1111\/aor.15056","DOI":"10.1111\/aor.15056"},{"issue":"5","key":"763_CR76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/aor.12780","volume":"41","author":"D Horvath","year":"2017","unstructured":"Horvath D, Byram N, Karimov JH, Kuban B, Sunagawa G, Golding LAR, et al. Mechanism of Self-Regulation and In Vivo Performance of the Cleveland Clinic Continuous-Flow Total Artificial Heart. Artif Organs. 2017;41(5):411\u20137. https:\/\/doi.org\/10.1111\/aor.12780.","journal-title":"Artif Organs"},{"issue":"5","key":"763_CR77","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/aor.12778","volume":"41","author":"JH Karimov","year":"2017","unstructured":"Karimov JH, Horvath DJ, Okano S, Goodin M, Sunagawa G, Byram N, et al. Thrombotic Depositions on Right Impeller of Double-Ended Centrifugal Total Artificial Heart In Vivo. Artif Organs. 2017;41(5):476\u201381. https:\/\/doi.org\/10.1111\/aor.12778.","journal-title":"Artif Organs"},{"issue":"6","key":"763_CR78","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/mat.0000000000001581","volume":"68","author":"MS Goodin","year":"2022","unstructured":"Goodin MS, Horvath DJ, Kuban BD, Polakowski AR, Fukamachi K, Flick CR, et al. Computational Fluid Dynamics Model of Continuous-Flow Total Artificial Heart: Right Pump Impeller Design Changes to Improve Biocompatibility. Asaio j. 2022;68(6):829\u201338. https:\/\/doi.org\/10.1097\/mat.0000000000001581.","journal-title":"Asaio j"},{"issue":"7","key":"763_CR79","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/MAT.0000000000001926","volume":"69","author":"T Kuroda","year":"2023","unstructured":"Kuroda T, Kuban BD, Miyamoto T, Miyagi C, Polakowski AR, Flick CR, et al. Artificial Deep Neural Network for Sensorless Pump Flow and Hemodynamics Estimation During Continuous-Flow Mechanical Circulatory Support. ASAIO J. 2023;69(7):649\u201357. https:\/\/doi.org\/10.1097\/MAT.0000000000001926.","journal-title":"ASAIO J"},{"issue":"2","key":"763_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MAT.0000000000002076","volume":"70","author":"T Kuroda","year":"2024","unstructured":"Kuroda T, Miyagi C, Polakowski AR, Flick CR, Kuban BD, Fukamachi K, et al. Cleveland Clinic Continuous-Flow Total Artificial Heart: Progress Report and Technology Update. ASAIO J. 2024;70(2):116\u201323. https:\/\/doi.org\/10.1097\/MAT.0000000000002076.","journal-title":"ASAIO J"},{"issue":"3","key":"763_CR81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10047-018-1039-0","volume":"21","author":"K Fukamachi","year":"2018","unstructured":"Fukamachi K, Karimov JH, Byram NA, Sunagawa G, Dessoffy R, Miyamoto T, et al. Anatomical study of the Cleveland Clinic continuous-flow total artificial heart in adult and pediatric configurations. J Artif Organs. 2018;21(3):383\u20136. https:\/\/doi.org\/10.1007\/s10047-018-1039-0.","journal-title":"J Artif Organs"},{"issue":"10","key":"763_CR82","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jocs.12823","volume":"31","author":"A Cheng","year":"2016","unstructured":"Cheng A, Trivedi JR, Van Berkel VH, Massey HT, Slaughter MS. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation. J Card Surg. 2016;31(10):648\u201353. https:\/\/doi.org\/10.1111\/jocs.12823.","journal-title":"J Card Surg"},{"issue":"2","key":"763_CR83","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/aor.14884","volume":"49","author":"J Ferrall","year":"2025","unstructured":"Ferrall J, Vaidya AS, Kawaguchi ES, Patel SG, Lee RC, Lee ES, et al. Comparison of waitlist and post-transplant outcomes in patients supported with total artificial heart versus continuous biventricular assist devices. Artif Organs. 2025;49(2):281\u201391. https:\/\/doi.org\/10.1111\/aor.14884.","journal-title":"Artif Organs"},{"key":"763_CR84","doi-asserted-by":"publisher","unstructured":"Arabia FA, Murray CF, Cantor R, Deng L, Gopalan R, Amabile O et al. Heart Transplant Outcomes After Total Artificial Heart. Transplant Proc. 2023;55(7):1664-73. https:\/\/doi.org\/10.1016\/j.transproceed.2023.05.020","DOI":"10.1016\/j.transproceed.2023.05.020"},{"key":"763_CR85","doi-asserted-by":"publisher","first-page":"1677940","DOI":"10.3389\/fcvm.2025.1677940","volume":"12","author":"Q Ding","year":"2025","unstructured":"Ding Q, Chen C, Xu Z, Zhang N, Pan J, Ge M. A case report: corheart 6 biventricular assist device therapy for end-stage heart failure in dilated cardiomyopathy. Front Cardiovasc Med. 2025;12:1677940. https:\/\/doi.org\/10.3389\/fcvm.2025.1677940.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"763_CR86","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/aor.14933","volume":"49","author":"S Knigge","year":"2025","unstructured":"Knigge S, Dogan G, Deniz E, Hanke J, Merzah A, Berliner D, et al. Two Coupled Continuous-Flow Ventricular Assist Devices as a Novel BIVAD With One Driveline: Acute Animal Study Results. Artif Organs. 2025;49(3):525\u201331. https:\/\/doi.org\/10.1111\/aor.14933.","journal-title":"Artif Organs"},{"key":"763_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/aor.70064","author":"JD Schmitto","year":"2026","unstructured":"Schmitto JD, Hanke JS, Knigge S, Darbaidze Z, Kong F, Heilmann T, et al. A Novel Biventricular Assist Device With a Single Driveline: A Report on the First Patient Treated. Artif Organs. 2026. https:\/\/doi.org\/10.1111\/aor.70064.","journal-title":"Artif Organs"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-026-00763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-026-00763-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-026-00763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:24:22Z","timestamp":1778664262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-026-00763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1007\/s11897-026-00763-y","relation":{},"ISSN":["1546-9549"],"issn-type":[{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nir Uriel serve as the National Co-Principal Investigator for the MOMENTUM 3 and ARIES studies. He also received grant support from Abbott and Abiomed. Nir Uriel serve on the medical advisory board of Leviticus, Livemetric and Revamp. Gabriel T. Sayer has received consulting fees from Abbott. The other authors report no financial relationships or institutional affiliations with any organization having a financial interest in the subject matter discussed herein. This includes employment, advisory roles, honoraria, stock ownership, expert testimony, grants, patents, or royalties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"24"}}